Despite government reassurances, health experts have serious concerns about the long-term implications of the withdrawal of funding for HIV/Aids treatment programmes.
AllAfrica on MSN7d
Africa: New Dosing Guidance for Dolutegravir Allows Neonates Born to Mothers with HIV to Access this ARV Drug for the First Time - CROI ResearchThe PETITE-DTG study evaluated dolutegravir (DTG) — a drug that revolutionized HIV treatment in adults and children — in ...
Ugandan HIV activists Barbara Kemigisa shows Antiretroviral (ARV) packagings and tablets in an art design encouraging people infected with HIV to use the ARVs and fight against stigmatisation ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback